Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,099,000 | -4,261,000 | 78,000 | 25,000 | -1,000,000 |
| Depreciation Amortization | 1,557,000 | 1,162,000 | 781,000 | 399,000 | 1,722,000 |
| Income taxes - deferred | -696,000 | -656,000 | -502,000 | -233,000 | -985,000 |
| Accounts receivable | N/A | N/A | N/A | N/A | -394,000 |
| Other Working Capital | -2,188,000 | -1,627,000 | -1,002,000 | -666,000 | -896,000 |
| Other Operating Activity | 6,642,000 | 6,267,000 | 1,223,000 | 780,000 | 2,301,000 |
| Operating Cash Flow | $1,216,000 | $885,000 | $578,000 | $305,000 | $748,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -511,000 | -348,000 | -214,000 | -122,000 | -182,000 |
| Purchase Of Investment | -55,000 | N/A | N/A | N/A | -8,000 |
| Sale Of Investment | 12,000 | 12,000 | 9,000 | N/A | N/A |
| Other Investing Activity | 1,417,000 | 1,058,000 | 770,000 | 374,000 | 1,545,000 |
| Investing Cash Flow | $863,000 | $722,000 | $565,000 | $252,000 | $1,355,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 550,000 | 231,000 | N/A | N/A | 500,000 |
| Debt Issued | N/A | N/A | N/A | N/A | 2,083,000 |
| Debt Repayment | -1,871,000 | -1,871,000 | -700,000 | -700,000 | -3,944,000 |
| Other Financing Activity | -564,000 | -120,000 | -3,000 | 0 | -565,000 |
| Financing Cash Flow | $-1,885,000 | $-1,760,000 | $-703,000 | $-700,000 | $-1,926,000 |
| Exchange Rate Effect | 8,000 | 5,000 | -13,000 | -28,000 | 16,000 |
| Beginning Cash Position | 1,975,000 | 1,975,000 | 1,975,000 | 1,975,000 | 1,782,000 |
| End Cash Position | 2,177,000 | 1,827,000 | 2,402,000 | 1,804,000 | 1,975,000 |
| Net Cash Flow | $202,000 | $-148,000 | $427,000 | $-171,000 | $193,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,216,000 | 885,000 | 578,000 | 305,000 | 748,000 |
| Capital Expenditure | -578,000 | -402,000 | -259,000 | -128,000 | -525,000 |
| Free Cash Flow | 638,000 | 483,000 | 319,000 | 177,000 | 223,000 |